Phase II Trial of Pembrolizumab in Combination With Bevacizumab for Untreated Melanoma Brain Metastases. Weiss SA, Djureinovic D, Wei W, Tran T, et al. J Clin Oncol 2025 Mar 6:JCO2402219. doi: 10.1200/JCO-24-02219.

Read + Share

Amedeo Smart

Independent Medical Education

Weiss SA, Djureinovic D, Wei W, Tran T, et al. Phase II Trial of Pembrolizumab in Combination With Bevacizumab for Untreated Melanoma Brain Metastases. J Clin Oncol 2025 Mar 6:JCO2402219. doi: 10.1200/JCO-24-02219.
PMID: 40048689